Quick Answer
Astrana Health, Inc. reported Long Term Debt of $990.90 million for the year ending 2025.
- Astrana Health, Inc. showed an increase of +133.0% in Long Term Debt from 2024 to 2025.
- This data is from Astrana Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $234.15 million | Q1 2020: $230.11 million | Q2 2020: $230.46 million | Q3 2020: $226.05 million | Q1 2021: $226.94 million | Q2 2021: $182.71 million | Q3 2021: $182.81 million | Q1 2022: $183.10 million | Q2 2022: $199.07 million | Q3 2022: $199.15 million | Q1 2023: $204.94 million | Q2 2023: $205.14 million | Q3 2023: $206.21 million | Q1 2024: $368.45 million | Q2 2024: $425.01 million | Q3 2024: $423.12 million | Q1 2025: $403.89 million | Q2 2025: $401.06 million | Q3 2025: $1.00 billion.
- Historical annual values: Fiscal year 2025: $990.90 million | Fiscal year 2024: $425.30 million | Fiscal year 2023: $258.94 million | Fiscal year 2022: $203.39 million | Fiscal year 2021: $182.92 million | Fiscal year 2020: $230.21 million | Fiscal year 2019: $232.17 million | Fiscal year 2018: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: